IGHS had the pleasure to welcome SanderStrothmann in Coimbra
The IGHS Group, through its subsidiary INNOV-CELL THERAPEUTICS, has been focused on the development of innovative biotechnological-based therapeutic solutions in the dermatological sector.
This week we had the pleasure to welcome in Coimbra some elements of the german multinational company SanderStrothmann GmbH, with the main goal to strengthen our commercial relationship.
Two days of intense work where were discussed new projects that resulted in the guarantee of the development of new innovative products to reinforce the Kelo.Cell product line.
Our guests had also the opportunity to visit BASI Laboratories, located in Mortágua.
Combining innovation and high quality, next year IGHS will have new products, developed by SanderStrothmann’s R&D, available on the market.
Another investment of IGHS Group focused on the overall health of the patient.
New Partnership with REGEnLIFE
The director’s board of REGEnLIFE met yesterday in Paris with the Chairman of IGHS Group, Dr. José Alexandre Cunha and the Commercial Counsellor António Sousa to develop...Read more
The IGHS Group continues its demand for recognition of its work carried out across borders.
Due to the high standards of quality at both technical and human levels that characterise the projects in which the IGHS is involved, an invitation by the Ministry of Health of Uzbekistan to participate in meetings was extended to our group.Read more